Status:
COMPLETED
Improvement of Sensibility in the Foot in Diabetic Patients Induced by EMLA-application to the Lower Leg
Lead Sponsor:
Lund University Hospital
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Sensory input from the foot as well as all other body parts results in activation of sensory cortex. It is well known that the cortical body map is experienced-dependant and can rapidly change in res...
Eligibility Criteria
Inclusion
- Adult patients (18-75 years) suffering from diabetes with subjective sensory impairment in the sole of the foot.
Exclusion
- Patients with painful neuropathy or established ulcer formation in toes or sole of the foot, known hypersensitivity to local anaesthetics, major vascular reconstructions, communication problems due to severe language problems.
- Patients with pacemakers or magnetic implants or suffering from claustrophobia will not be subjected to fMRI-investigation.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00959595
Start Date
November 1 2008
End Date
January 1 2010
Last Update
December 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Hand Surgery, Malmö University Hospital
Malmo, Sweden, SE-205 02